Variant report
Variant | esv2762335 |
---|---|
Chromosome Location | chr3:70069112-70074892 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000240405 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9873906 | chr3:70069112-70069113 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs9841257 | chr3:70069150-70069151 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs182781442 | chr3:70069170-70069171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6549263 | chr3:70069179-70069180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141912483 | chr3:70069196-70069197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75980880 | chr3:70069209-70069210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569170550 | chr3:70069220-70069221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531677367 | chr3:70069225-70069226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116266587 | chr3:70069242-70069243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139147499 | chr3:70069244-70069245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373461749 | chr3:70069258-70069259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547880810 | chr3:70069282-70069283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533855396 | chr3:70069318-70069319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570948568 | chr3:70069322-70069323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188898389 | chr3:70069344-70069345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553598625 | chr3:70069362-70069363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193250872 | chr3:70069378-70069379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149525137 | chr3:70069432-70069433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369698237 | chr3:70069446-70069447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146034320 | chr3:70069447-70069448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530352905 | chr3:70069455-70069456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575495284 | chr3:70069488-70069489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571102188 | chr3:70069499-70069500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555119450 | chr3:70069513-70069514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574951483 | chr3:70069519-70069520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540857612 | chr3:70069540-70069541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74425481 | chr3:70069544-70069545 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377372499 | chr3:70069556-70069557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369541345 | chr3:70069572-70069573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546209054 | chr3:70069588-70069589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184691431 | chr3:70069607-70069608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12171315 | chr3:70069611-70069612 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs548524213 | chr3:70069618-70069619 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371833191 | chr3:70069620-70069621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13080062 | chr3:70069621-70069622 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs139988028 | chr3:70069630-70069631 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188915866 | chr3:70069675-70069676 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575394943 | chr3:70069678-70069679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115586760 | chr3:70069690-70069691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374710022 | chr3:70069701-70069702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537724190 | chr3:70069746-70069747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539158606 | chr3:70069778-70069779 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs78050330 | chr3:70069787-70069788 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs377360475 | chr3:70069806-70069807 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs569334125 | chr3:70069873-70069874 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs538117520 | chr3:70069875-70069876 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs554949713 | chr3:70069876-70069877 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs575105771 | chr3:70069896-70069897 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs191794984 | chr3:70069906-70069907 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs17785152 | chr3:70069907-70069908 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Mental retardation | 17847001 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:70063800-70098000 | Weak transcription | Aorta | Aorta |
2 | chr3:70068000-70069600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr3:70069400-70071400 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr3:70069600-70071400 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr3:70069600-70071400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr3:70069600-70071400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr3:70069600-70071400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr3:70069800-70071400 | Enhancers | Primary B cells from cord blood | blood |
9 | chr3:70070000-70071000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr3:70071400-70072200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
11 | chr3:70071400-70073000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr3:70071400-70073000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr3:70073000-70073200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr3:70073000-70073800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr3:70073000-70074200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |